CIBC Bancorp USA »

Heron Therapeutics shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 16k 1.26

More positions owned by CIBC Bancorp USA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Ishares Tr U.s. Real Es Etf (IYR)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Linde SHS (LIN)
Cognizant Technology Solutio Cl A (CTSH)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for CIBC Bancorp USA

Top funds holding Heron Therapeutics

Rubric Capital Management
Adage Capital Partners GP
BlackRock
Clearline Capital
Velan Capital Investment Management
Vanguard Group
Palisade Capital Management
Tejara Capital
Baker Bros. Advisors
State Street Corporation
Geode Capital Management
Tang Capital Management
JW Asset Management
D. E. Shaw & Co
UBS Group

View all funds holding Heron Therapeutics